CONMED Corporation Statistics
Share Statistics
CONMED Corporation has 30.89M shares outstanding. The number of shares has increased by 0.36% in one year.
| Shares Outstanding | 30.89M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.2% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 30.03M |
| Failed to Deliver (FTD) Shares | 123 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 2.38M, so 7.7% of the outstanding shares have been sold short.
| Short Interest | 2.38M |
| Short % of Shares Out | 7.7% |
| Short % of Float | 7.92% |
| Short Ratio (days to cover) | 6.57 |
Valuation Ratios
The PE ratio is 52.1 and the forward PE ratio is 15.45. CONMED Corporation's PEG ratio is 0.29.
| PE Ratio | 52.1 |
| Forward PE | 15.45 |
| PS Ratio | 2.7 |
| Forward PS | 1.4 |
| PB Ratio | 4.03 |
| P/FCF Ratio | 31.59 |
| PEG Ratio | 0.29 |
Enterprise Valuation
CONMED Corporation has an Enterprise Value (EV) of 4.33B.
| EV / Earnings | 67.1 |
| EV / Sales | 3.47 |
| EV / EBITDA | 22.47 |
| EV / EBIT | 33.07 |
| EV / FCF | 40.68 |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 1.16.
| Current Ratio | 1.98 |
| Quick Ratio | 0.96 |
| Debt / Equity | 1.16 |
| Total Debt / Capitalization | 53.8 |
| Cash Flow / Debt | 0.13 |
| Interest Coverage | 3.29 |
Financial Efficiency
Return on equity (ROE) is 0.08% and return on capital (ROIC) is 5.71%.
| Return on Equity (ROE) | 0.08% |
| Return on Assets (ROA) | 0.03% |
| Return on Capital (ROIC) | 5.71% |
| Revenue Per Employee | 311.19K |
| Profits Per Employee | 16.11K |
| Employee Count | 4.00K |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.79 |
Taxes
| Income Tax | 16.37M |
| Effective Tax Rate | 0.2 |
Stock Price Statistics
The stock price has increased by -38.86% in the last 52 weeks. The beta is 1.46, so CONMED Corporation's price volatility has been higher than the market average.
| Beta | 1.46 |
| 52-Week Price Change | -38.86% |
| 50-Day Moving Average | 71.77 |
| 200-Day Moving Average | 70.99 |
| Relative Strength Index (RSI) | 40.79 |
| Average Volume (20 Days) | 403.76K |
Income Statement
In the last 12 months, CONMED Corporation had revenue of 1.24B and earned 64.46M in profits. Earnings per share was 2.1.
| Revenue | 1.24B |
| Gross Profit | 676.25M |
| Operating Income | 130.79M |
| Net Income | 64.46M |
| EBITDA | 192.48M |
| EBIT | 130.79M |
| Earnings Per Share (EPS) | 2.1 |
Balance Sheet
The company has 24.30M in cash and 991.25M in debt, giving a net cash position of -966.96M.
| Cash & Cash Equivalents | 24.30M |
| Total Debt | 991.25M |
| Net Cash | -966.96M |
| Retained Earnings | 452.53M |
| Total Assets | 2.32B |
| Working Capital | 358.69M |
Cash Flow
In the last 12 months, operating cash flow was 125.35M and capital expenditures -19.03M, giving a free cash flow of 106.32M.
| Operating Cash Flow | 125.35M |
| Capital Expenditures | -19.03M |
| Free Cash Flow | 106.32M |
| FCF Per Share | 3.47 |
Margins
Gross margin is 54.33%, with operating and profit margins of 10.51% and 5.18%.
| Gross Margin | 54.33% |
| Operating Margin | 10.51% |
| Pretax Margin | 6.49% |
| Profit Margin | 5.18% |
| EBITDA Margin | 15.46% |
| EBIT Margin | 10.51% |
| FCF Margin | 8.54% |
Dividends & Yields
CNMD pays an annual dividend of $0.8, which amounts to a dividend yield of 1.15%.
| Dividend Per Share | $0.80 |
| Dividend Yield | 1.15% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 18.96% |
| Earnings Yield | 3.11% |
| FCF Yield | 5.09% |
Analyst Forecast
The average price target for CNMD is $75.5, which is 11.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $75.5 |
| Price Target Difference | 11.8% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Stock Splits
The last stock split was on Sep 10, 2001. It was a forward split with a ratio of 3:2.
| Last Split Date | Sep 10, 2001 |
| Split Type | forward |
| Split Ratio | 3:2 |
Scores
| Altman Z-Score | 2.25 |
| Piotroski F-Score | 8 |